Major Neurocognitive Disorder: The Beginning and the End. Making the Diagnosis and Addressing Distressing Behavior
neuroscienceCME WebcastPremiere Date: Friday, March 9, 2018
This activity offers CE credit for:%>
- Physicians (CME)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Saturday, March 9, 2019
|W. Vaughn McCall, MD, MS
Professor and Case Distinguished University Chairman
The Department of Psychiatry and Health Behavior
Medical College of Georgia
This video is a replay of a plenary session from the 10th Annual Chair Summit Master Class for Neuroscience Professional Development held in New Orleans, LA on November 16-18, 2017.
At the end of this CE activity, participants should be able to:
- Review the importance of early detection and intervention in AD
- Integrate emerging tools and biomarker assessments into the diagnosis and treatment of AD
- Evaluate emerging data on the efficacy and safety of agents for AD, including agents in development for treating cognitive and behavioral complications associated with AD
This activity is supported by an educational grant from Biogen MA, Inc. and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other nonphysician healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.
CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following informaiton is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. McCall reports that he receives grant and research support from Merck & Co. Inc. He is a consultant for Multiple Energy Technologies and Anthem Insurance
Howard Bliwise, MD (peer reviewer) has no disclosures to report.
Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
Daniela V. DiBiase, MS (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).